These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 23154229

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Hemodialysis to remove anticoagulant dabigatran during emergencies].
    Carrizo A, Campbell S.
    Medicina (B Aires); 2014; 74(2):121-3. PubMed ID: 24736256
    [Abstract] [Full Text] [Related]

  • 25. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
    Mantha S, Ansell J.
    Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Safe use of hemodialysis for dabigatran removal before cardiac surgery.
    Wanek MR, Horn ET, Elapavaluru S, Baroody SC, Sokos G.
    Ann Pharmacother; 2012 Sep; 46(9):e21. PubMed ID: 22872748
    [Abstract] [Full Text] [Related]

  • 28. Hemodialysis for the treatment of pulmonary hemorrhage from dabigatran overdose.
    Chen BC, Sheth NR, Dadzie KA, Smith SW, Nelson LS, Hoffman RS, Winchester JF.
    Am J Kidney Dis; 2013 Sep; 62(3):591-4. PubMed ID: 23597859
    [Abstract] [Full Text] [Related]

  • 29. Dabigatran: will it change clinical practice?
    Wartak SA, Bartholomew JR.
    Cleve Clin J Med; 2011 Oct; 78(10):657-64. PubMed ID: 21968472
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Acute ischemic stroke treated with intravenous tissue plasminogen activator in a patient taking dabigatran with radiographic evidence of recanalization.
    Sangha N, El Khoury R, Misra V, Lopez G.
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):917.e5-8. PubMed ID: 22683118
    [Abstract] [Full Text] [Related]

  • 35. Relation between dabigatran concentration, as assessed using the direct thrombin inhibitor assay, and activated clotting time/activated partial thromboplastin time in patients with atrial fibrillation.
    Okubo K, Kuwahara T, Takagi K, Takigawa M, Nakajima J, Watari Y, Nakashima E, Yamao K, Fujino T, Tsutsui H, Takahashi A.
    Am J Cardiol; 2015 Jun 15; 115(12):1696-9. PubMed ID: 25918026
    [Abstract] [Full Text] [Related]

  • 36. Ischemic stroke and intestinal bleeding under dabigatran in metabolic myopathy.
    Finsterer J, Stöllberger C, Paul G, Bastovansky A.
    Cardiovasc Ther; 2013 Dec 15; 31(6):e111-4. PubMed ID: 24279385
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Exfoliative esophagitis while taking dabigatran].
    Scheppach W, Meesmann M.
    Dtsch Med Wochenschr; 2015 Apr 15; 140(7):515-8. PubMed ID: 25826037
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.